| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1997;28:1867-1870.)
© 1997 American Heart Association, Inc.
Articles |
From the Jewish Rehabilitation Hospital Research Center (E.K., N.K.-B., R.B., S.R.), Speech and Language Pathology (F.S.), Nursing (M.L.), Adult Education (P.G.), Laval, Quebec; and McGill University, Department of Linguistics (E.K.), and School of Physical and Occupational Therapy (N.K.-B.), Montreal, Quebec, Canada.
Correspondence to Dr Eva Kehayia, PhD, Jewish Rehabilitation Hospital, 3205 Place Alton Goldbloom, Laval, Quebec, Canada H7V 1R2. E-mail inek{at}musicb.mcgill.ca
| Abstract |
|---|
|
|
|---|
Methods The study involved a retrospective chart review of 207 charts of patients with stroke admitted to the Jewish Rehabilitation Hospital (JRH), Laval, Canada. Patients were classified into three groups according to level of expressive aphasia: those without aphasia, those with mild-to-moderate aphasia, and those severe aphasia. Information on medications used primarily for pain management was elicited for the first 21 days and the last 5 days of hospitalization. Any substitution, increase, elimination, or addition of pain medication during hospitalization was also monitored.
Results and Conclusions While the findings indicate that pain medication prescriptions were similar for all patients, a significantly smaller number of individuals with aphasia received pro re nata (prn) "as required" pain medication when compared with those without aphasia, for the first 21 days and for the last 5 days of hospitalization at the JRH. Similarly, when daily dose was monitored for the same time periods, individuals with aphasia were found to have received less medication for pain than those without aphasia.
Key Words: cerebrovascular disorders aphasia pain
| Introduction |
|---|
|
|
|---|
In the hospital nurses administer medication for pain, particularly "prn" (pro re nata, "as required"), upon request of the patient or based on their personal judgment of a patient's needs. Under the hypothesis that those with aphasia may be unable to express their need for medication, the question arises as to whether individuals with aphasia are receiving medication that is similar in frequency and dose to that received by those without aphasia. If those with aphasia experience pain similar to those without, then the two groups should display similar patterns of pain medication use. An extensive search of the literature failed to reveal any information that has addressed this issue.
Thus, the global objective of this study was to compare pain medication use in individuals with and those without aphasia. More specifically, as difficulty to communicate increases with severity of aphasia, we investigated whether there exists an association between severity and overall pain medication use as indicated (1) by the proportion of individuals medicated according to aphasia severity and (2) by the dosage of pain medication used according to aphasia severity. Second, we studied substitution, increase, elimination, and addition in pain medication use during hospitalization according to severity of aphasia.
| Subjects and Methods |
|---|
|
|
|---|
Inclusion in the study required a primary diagnosis of stroke at the time of admission to the JRH as indicated by the medical summary and CT scan from the acute care hospital and a minimum inpatient rehabilitation stay of 4 weeks. Patients with severe cognitive and/or severe psychological problems, as indicated in the neuropsychology report, were excluded. Those with a previous admission for stroke at the JRH were excluded because it was possible that during a previous stroke admission the nursing staff may have become acquainted with the patient's pain-related behaviors. This project was approved by the Research Ethics Committee of the Jewish Rehabilitation Hospital.
Procedure
For each patient, information on basic sociodemographic
variables (eg, age, sex, language or languages spoken and
understood) was abstracted from the admission records. Information
on site of lesion, comorbid conditions, presence of hemiplegia,
paresis, and hemineglect was also recorded from the patient's
medical records. Information on the presence of aphasia and its
classification in terms of type and severity was obtained for those
with aphasia from the records of the treating speech-language
pathologist. Standard assessment and documentation procedures were in
place in the Speech Pathology Department during the entire study
period.
Classification of Aphasia Severity
Patients with aphasia are assessed by the speech-language
pathologist, within 72 hours of admission. Assessment is based on
standardized tests, including the Boston Diagnostic Aphasia
Examination,8 the Western Aphasia Battery9
for English-speaking patients, and the Montreal-Toulouse Aphasia
Battery10 for French-speaking patients. Results are
summarized in an initial report. This report was reviewed by the
collaborating speech-language pathologist and the principle
investigator who together reached a determination regarding aphasia
classification. Patients without an apparent language deficit were not
evaluated by a speech-language pathologist. Verification of the
appropriateness of these individuals to be classified as nonimpaired
was obtained through a review of the reports of all disciplines.
Ascertainment of Pain Medication Use
Information on medications used for pain management was elicited
from the medication records completed on a 24-hour basis by the
nurse responsible for medication administration. The information
included the medication name, dosage, and time of administration.
Before the initiation of this study, meetings were held with a
multidisciplinary team to determine medications commonly used to manage
pain in this clientele. After much deliberation it was decided that the
following medications would be considered as being used only for pain
management: acetaminophen without codeine and with codeine,
naproxen, indomethacin, and
acetylsalicylic (ASA), as these categories
accounted for almost 100% of the pain medications used. Other ASA
medications, such as Entrophen, that may or may not have been used for
pain control, were excluded from the analyses.
Pain medication used for the first 21 days and the final 5 days of hospitalization at the rehabilitation center was recorded. After the first 21 days any pain medication administered for more than 24 hours was also recorded, for a period up to 7 days. In addition, medication prescribed both in the acute care hospital and upon admission to the rehabilitation facility was abstracted from the physician's prescription orders. Finally, the addition of any new pain medication, the substitution of one pain medication for another, the increase in dosage, or the elimination of a prescribed pain medication were identified by reviewing the daily medication records.
Data Analysis
The percentage of individuals for which pain medication
prescriptions had been completed in the acute care hospital was
calculated according to group (no, mild-to-moderate, severe aphasia). A
similar comparison across groups was performed using the prescription
orders from the rehabilitation setting. The number of individuals for
whom pain medication was both prescribed and used was analyzed
according to group using
2 analyses.
Because it was hypothesized that the biggest differences in use between
groups would exist early in the hospitalization, preliminary
calculations focused on differences in dosage and numbers of
individuals receiving pain medication during the first 7 days. Further
analyses explored these variables in the first 21 days and
again in the final 5 days of rehabilitation hospital stay. Finally, the
total number of substitutions, dose increases, eliminations, or
additions of pain medication according to group were calculated.
| Results |
|---|
|
|
|---|
|
The three groups were similar with respect to sex, age, and total number of comorbid conditions. As anticipated, the majority of the patients with aphasia had experienced a left-hemisphere stroke, whereas those without aphasia had experienced a right-hemisphere stroke. The length of stay for the two groups with aphasia was longer than for those without aphasia.
Table 2
describes the number of
individuals in each group for whom pain medication prescriptions had
been completed in the acute care hospital. Across the three groups,
2 analyses comparing the proportions of
individuals in each group that received prn prescriptions for pain
relief revealed no significant differences
(
2=1.18; P=.55, df=2).
Similarly, when comparisons were made in prn pain medication upon
admission to the rehabilitation hospital, there were no differences in
the percentages of individuals for whom pain medications were ordered
across the three groups (
2=1.43;
P=.49, df=2). When the number of individuals for
whom acetaminophen was prescribed and used across the three
groups in the first 21 days of rehabilitation hospitalization, a
significant difference was found in the proportions of those prescribed
and those who actually used acetaminophen across the three
groups; the greatest proportion of use was in those without aphasia
(88%), followed by those with aphasia mild-to-moderate (51%) and
severe (55%) aphasia (
2=10.79;
P<.01, df=2). Only 4 of 34 people without
aphasia for whom acetaminophen had been prescribed did not
receive any during the first 21 days of hospitalization, while 15 of 33
individuals with severe aphasia did not receive any. In the last 5 days
of rehabilitation hospitalization a trend was found that was similar to
that of the earlier period of hospitalization, with the highest
proportion of use in those without aphasia (56%), as compared with
those with mild-to-moderate and those with severe aphasia, 29% and
27%, respectively (
2=7.13; P<.05,
df=2).
|
Fig 1
details the number of individuals
who received acetaminophen in the first 21 days of
hospitalization according to severity of aphasia. Overall there were
consistently more individuals without aphasia receiving
acetaminophen. This difference between groups was most
pronounced in the first few days of rehabilitation hospitalization. For
example, on day 4, 4 individuals with severe aphasia and 5 with
mild-to-moderate aphasia received acetaminophen as compared
with 13 individuals without aphasia.
|
When the total daily dosage was compared over the first 21 days of
hospitalization (Fig 2
), the group of
those with severe aphasia received less acetaminophen on
each of the days when compared with the group without aphasia. The
dosage received by the group with mild-to-moderate aphasia was almost
always lower than that received by the group without aphasia, and at
times even lower than the dosage received by the group with severe
aphasia. When the three groups were compared in terms of the number of
individuals with a substitution, addition, increase, or elimination in
pain medications during the entire hospital stay, no significant
differences were found for these four variables.
|
| Discussion |
|---|
|
|
|---|
The findings of this study indicate that individuals with aphasia are receiving medication for pain that differs in frequency and quantity from that received by patients without aphasia. The Jewish Rehabilitation Hospital has an interdisciplinary team extensively trained in the treatment of stroke and annually admits a large number of individuals with stroke to its stroke unit. Thus, it is likely that the findings of differential pain medication use witnessed in this hospital would also be found in other similar settings.
A potential limitation of this study concerns the classification of the three groups according to level of aphasia. While it is highly unlikely, in a rehabilitation center where each individual is seen by numerous health professionals, that an individual with aphasia would have been classified as nonaphasic, it is possible, that within the group of those with aphasia there was some misclassification. This may in part explain why no large differences were seen in the dosage and frequency of prn pain medication use between the mild-to-moderate and severe groups, while statistically significant differences were found between those with and those without aphasia.
One of the unanswered questions of this study is whether those with aphasia suffered from less pain than that experienced by those without aphasia. If the answer to this question is yes, then it might explain why this group received less pain medication. However, if as a group they had pain experience similar to those without aphasia, then the plausible explanation is that the presence of aphasia limited their ability to request pain medication. The finding that the number of comorbidities was similar across the groups lends some support for the latter supposition. Those with aphasia did remain in the hospital longer than those without aphasia, which may imply that they were a "sicker" group. Yet, if this group had been sicker, they would potentially have needed more pain medication, not less.
This study has raised concern that individuals with aphasia may not be receiving proper management for pain because of our failure to correctly identify and assess their needs. On the basis of these findings, a second phase of this research has already been launched to assess the use of various nonverbal assessment scales to elicit information on pain severity from those with aphasia.
| Acknowledgments |
|---|
Received March 24, 1997; revision received June 18, 1997; accepted June 18, 1997.
| References |
|---|
|
|
|---|
2. Van Langerberghe HVK, Hogan BM. Degree of pain and grade off subluxation in the painful hemiplegic shoulder. Scand J Rehabil Med. 1988;20:161-166.[Medline] [Order article via Infotrieve]
3. Ferro JM, Lelo TP, Oliveira V, Salgalo AV, Crespo M, Canhac P, Pinto AN. A multivariate study of headache associated with ischemic stroke. Headache. 1995;35:315-319.[Medline] [Order article via Infotrieve]
4.
Kumral E, Bogusslavsky J, Van Melle, G Regli, F Pierre
P. Headache at stroke onset: the Lauzanne Stroke
Registry. J Neurol Neurosurg Psychiatry. 1995;58:490-492.
5.
Jorgensen HS, Jerpersen HF, Nakayama H, Raaschou HO,
Olset TS. Headache in stroke: The Copenhagen Stroke
Study. Neurol. 1994;44:1793-1797.
6. Arboix A, Massons J, Oliveres M, Arribas MP, Titus F. Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalal. 1994;14:37-40.
7. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61:187-193.[Medline] [Order article via Infotrieve]
8. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1983.
9. Kertesz A. Western Aphasia Battery. New York, NY: Academic Press; 1982.
10. Nespoulous JL, Lecours AR, Lafond D, Lemay A, Puel M, Joanette Y, Cot F, Rascol A. Montreal-Toulouse `M1-BETA' Aphasia Battery; 1986.
This article has been cited by other articles:
![]() |
C. Sackley, N. Brittle, S. Patel, J. Ellins, M. Scott, C. Wright, and M. E. Dewey The Prevalence of Joint Contractures, Pressure Sores, Painful Shoulder, Other Pain, Falls, and Depression in the Year After a Severely Disabling Stroke Stroke, December 1, 2008; 39(12): 3329 - 3334. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Korner-Bitensky, E. Kehayia, N. Tremblay, B. Mazer, F. Singer, and J. Tarasuk Eliciting Information on Differential Sensation of Heat in Those With and Without Poststroke Aphasia Using a Visual Analogue Scale Stroke, February 1, 2006; 37(2): 471 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M Pomeroy, C. Frames, E. B Faragher, A. Hesketh, E. Hill, P. Watson, and C. J Main Reliability of a measure of post-stroke shoulder pain in patients with and without aphasia and/or unilateral spatial neglect Clinical Rehabilitation, June 1, 2000; 14(6): 584 - 591. [Abstract] [PDF] |
||||
![]() |
C. I. M. Price, R. H. Curless, and H. Rodgers Can Stroke Patients Use Visual Analogue Scales? Stroke, July 1, 1999; 30(7): 1357 - 1361. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |